Combined Epidermal Growth Factor Receptor and Beclin1 Autophagic Protein Expression Analysis Identifies Different Clinical Presentations, Responses to Chemo- and Radiotherapy, and Prognosis in Glioblastoma

<div>Patient with H-EGFR (a) and L-Beclin1 (b) pattern of protein expression in a GB. The arrows indicate the endothelium of vessels, negative for EGFR (a) and positive for Beclin1 (b) Immunohistochemistry, diaminobenzidine, original magnification ×200. The MRI T1-sequence with gadolinium (c) shows a multifocal GB with a left temporal (white arrow) and a parietooccipital lesion (red arrow).</div>

BioMed Research International

fig1

Figure 1

Figure 1: Combined Epidermal Growth Factor Receptor and Beclin1 Autophagic Protein Expression Analysis Identifies Different Clinical Presentations, Responses to Chemo- and Radiotherapy, and Prognosis in Glioblastoma 

Figure 1 | Combined Epidermal Growth Factor Receptor and Beclin1 Autophagic Protein Expression Analysis Identifies Different Clinical Presentations, Responses to Chemo- and Radiotherapy, and Prognosis in Glioblastoma 